On investigations full blood count were within normal values. His erythrocyte sedimentation rate (ESR) was 86 mm in first hour. Serum urea, creatinine and electrolytes were within normal limits. But, random blood sugar was 10.8 mmol/l. Glucose tolerance test was 12.60 mmol/l 1hr after 75 gm of glucose intake and 11.56 mmol/l after 2hrs. Chest radiographs and computerized tomographic scan (CT scan) showed a cavitary lesion in upper lobe of the left lung with a mass within it and a crescentic rim surrounding the mass. In that stage our confusion was whether the lesion was a mycetoma or a cavitating bronchogenic carcinoma. We went for CT guided FNAC which revealed no malignant cell or granuloma. But there were a good number of polymorphs, pulmonary malaise and weight loss are additional symptoms in aspergilloma that may be due to the underlying pulmonary disease. 6 Fever is an unusual finding in aspergilloma, which may be due to concurrent bacterial infection, allergic type III hypersensitivity response or possibly an overlap syndrome, such as chronic necrotizing Aspergillosis. 6, 7 Aspergillomas are not static lesions. They may increase, decrease or remain stable in size and only <10% of cases may lyse spontaneously. 6 Physical examination is generally nonspecific, like decreased breath sound or bronchial breath sounds or additional sounds. 8 The diagnosis is based on various features, among those the presence of radiological opacity with an air crescent sign is of specific importance. 1 This air crescent sign reflects the presence of a fungus ball in a parenchymal cavity. 1, 6, 7 Usually the size of the cavity is bigger than the ball, which forms a rim of air around most of the part of the ball. Hyphae of the Aspergillus fumigatus can be found in sputum, bronchial washings, FNAC (fine needle aspiration cytology) and post operative histopathological examination of the ball. The symptoms in our elderly patient with a history of heavy smoking gave rise to a suspicion of bronchogenic carcinoma. We went for CT guided FNAC from the lung lesion, which revealed fungal hyphae. Other alternative radiological differential diagnoses are disintegrating hydatid cyst, pulmonary abscess with necrosis, blood clot in a pulmonary cavity following haemorrhage. 7 Definitive treatment of aspergilloma is surgical resection, 9 but with a high morbidity and mortality (7-25%). 2 Surgical resection is restricted to patients with severe haemoptysis and adequate pulmonary function, and patients with poor prognosis. 10 Regarding medical treatment, a lot of regimen are available, which includes treatment with amphotericin B, sodium or potassium iodide, itraconazole and fluconazole. 1, 3, 4 Itraconazole is an orally active triazole antifungal agent with less toxicity, high tissue penetration and greater in vitro activity against Aspergillus fumigatus than amphotericin B. 11 Effective doses of itraconazole is usually 200 to 400 mg/d orally with a duration of treatment of 6 to 18 months. 12 Itraconazole, amphotericin B can be injected inside the mycetoma percutaneously under CT guidance, if response to oral medications is not adequate. 13 In our patient we choose oral itraconazole to which he responded satisfactorily. macrophage and fungal hyphae. Finally he was diagnosed as a case of Pulmonary Aspergilloma in healed tuberculous cavity with Diabetes Mellitus. We started treatment with oral Itraconazole (300mg daily) and he responded satisfactorily. On follow up after 1 month, there was no cough, chest pain, respiratory distress or fever.
Discussion:
Pulmonary aspergilloma frequently complicates an existing cavity that was due to tuberculosis in most cases. 1,2,4 Regnard et al reported growth of aspergilloma in a post-tuberculosis cavity in 69% of a series of 89 cases. 5 Most patients of pulmonary aspergilloma are asymptomatic. 3 Symptomatic patient commonly presents with cough, fever, shortness of breathing and hemoptysis (in 50 to 80% cases, which may be life-threatening). 3, 6, 7 Dyspnoea,
